91 related articles for article (PubMed ID: 16097450)
1. RT-PCR expression profiling of matrix metalloproteinases and their specific inhibitors in cell lines and fresh biopsies of squamous cell carcinomas of the head and neck.
Dünne AA; Mandic R; Falkenberg S; Dalchow CV; Sesterhenn AM; Werner JA
In Vivo; 2005; 19(5):943-8. PubMed ID: 16097450
[TBL] [Abstract][Full Text] [Related]
2. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
[TBL] [Abstract][Full Text] [Related]
4. Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract.
Dünne AA; Sesterhenn A; Gerisch A; Teymoortash A; Kuropkat C; Werner JA
Anticancer Res; 2003; 23(3B):2233-9. PubMed ID: 12894497
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Görögh T; Beier UH; Bäumken J; Meyer JE; Hoffmann M; Gottschlich S; Maune S
Head Neck; 2006 Jan; 28(1):31-9. PubMed ID: 16265652
[TBL] [Abstract][Full Text] [Related]
6. Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
Gentner B; Wein A; Croner RS; Zeittraeger I; Wirtz RM; Roedel F; Dimmler A; Dorlaque L; Hohenberger W; Hahn EG; Brueckl WM
Anticancer Res; 2009 Jan; 29(1):67-74. PubMed ID: 19331134
[TBL] [Abstract][Full Text] [Related]
7. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
8. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
9. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract.
Sengpiel V; Rost T; Görögh T; Rathcke IO; Werner JA
Anticancer Res; 2004; 24(4):2161-7. PubMed ID: 15330156
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
Sesterhenn AM; Mandic R; Dünne AA; Werner JA
Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
13. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
Pietruszewska W; Bojanowska-Poźniak K; Kobos J
Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of differential expression genes related to different metastasis potential of adenoid cystic carcinoma using restriction fragments differential display PCR].
Lu YG; Zhou HY; Ding LC; Mei Y; Xiong RH; Deng SS; Yang HJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):505-10. PubMed ID: 17029196
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
18. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
19. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
20. Expression of cancer testis antigens in head and neck squamous cell carcinomas.
Figueiredo DL; Mamede RC; Proto-Siqueira R; Neder L; Silva WA; Zago MA
Head Neck; 2006 Jul; 28(7):614-9. PubMed ID: 16475205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
